首页> 外文OA文献 >The utility of glomerular C4d immunostaining in renal biopsies in patients with immunoglobulin A nephropathy. A clinicopathological study
【2h】

The utility of glomerular C4d immunostaining in renal biopsies in patients with immunoglobulin A nephropathy. A clinicopathological study

机译:免疫球蛋白肾病患者肾活检肾小球C4D免疫染色的效用。临床病理学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The course of IgA nephropathy (IgAN) is highly variable and ranges from a totally benign condition to end-stage renal disease in approximately one third of cases. The identification of new prognostic markers could provide insights into the pathogenesis of IgAN and unveil new therapeutic avenues. Glomerular deposition of C4d is a marker of activation of the lectin pathway of complement. It is thought that activation of the lectin pathway in IgAN is associated with more severe renal damage, and more severe histological findings. In view of the above, the aim of the present study was to compare the clinical presentation, laboratory data, and histological lesions in the renal biopsy in IgAN patients with positive and negative staining for mesangial C4d depositions. Our study revealed that hypertension, severe proteinuria, a high level of serum creatinine, low eGFR at the time of presentation, as well as tubular atrophy/interstitial fibrosis > 50%, and endocapillary proliferation were significantly more frequent in the C4d (+) group than in the C4d (–) group. Based on our research, we can assume that mesangial immunoexpression of C4d seems to be a useful prognostic factor in IgAN.
机译:IgA肾病(IgAn)的过程是高度可变的,并且在大约三分之一的案件中从完全良性的肾病中到期良性条件。新预后标志物的鉴定可以为Igan的发病机制提供洞察,并揭示新的治疗途径。 C4d的肾小球沉积是凝集素衔接的活化的标志物。据认为,IGAN中凝集素途径的激活与更严重的肾损伤以及更严重的组织学发现有关。鉴于上述情况,本研究的目的是比较IgAn患者肾活组织检查中的临床介绍,实验室数据和组织学病变,用于阳性和阴性染色的Mesangial C4D沉积。我们的研究表明,高血压,严重的蛋白尿,高水平的血清肌酐,呈现时的低EGFR,以及管状萎缩/间质纤维化> 50%,在C4D(+)组中明显更频繁地频繁更频繁。比在C4D( - )组中。基于我们的研究,我们可以假设C4D的Mesangial免疫表达似乎是Igan的有用预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号